Hypofractionated radiotherapy to the prostate bed with intensity modulated radiation therapy (IMRT): a phase II trial.

Postoperative radiotherapy (RT) is a common therapy used for patients with prostate cancer. Although clinical trials have established the safety and efficacy of hypofractionation as a primary therapy, there are limited data in a postoperative setting.